A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury

Corcoran, Jonathan (Primary Investigator)
de Castro Vasconcelos Goncalves, Bia Goncalves (Co-Investigator)
Mant, T (Co-Investigator)

Wolfson SPaRC

Project: Research

Status	Finished
Effective start/end date	1/02/2018 → 30/09/2021

Collaborative partners

King's College London (lead)
University of Cambridge (Collaborating partner)
University of Surrey (Collaborating partner)
University of Oxford (Collaborating partner)

Funding

MRC Medical Research Council: £1,795,160.00
MRC Medical Research Council: £882,058.00